MyTomorrows Secures €4.5M Led by Balderton, Sofinnova
November 10, 2014
Healthcare platform MyTomorrows has raised €4.5 million in its first institutional financing led by Balderton Capital and Sofinnova Partners. The company uses existing legal frameworks to facilitate patient/physician access to a number of promising experimental treatments that are still in development but show initial signs of therapeutic benefit (and have an acceptable safety profile). The proceeds will develop MyTomorrows' platform with decision-making tools that identify those patients who will most benefit from the therapies; help establish business operations in the U.S.; and enable expansion into new disease areas, as well as European territories.